ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2586

Which Characteristics of Inflammatory Back Pain (CBP) Forecast the Presence of Sacroiliitis on Magnetic Resonance Imaging (MRI)? Results from the Esperanza Cohort

Victoria Navarro-Compán1, Raquel Almodóvar González2, Azucena Hernández3, Emma Beltrán4, Eugenio De Miguel5, Robert B. M. Landewé6, Désirée van der Heijde7 and Pedro Zarco8, 1Rheumatology, University Hospital La Paz and Leiden University Medical Center, Madrid, Spain, 2Rheumatology Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain, 3Rheumatology, Hospital Virgen de la Salud, Toledo, Spain, 4University General Hospital of Valencia, Valencia, Spain, 5Rheumatology, University Hospital La Paz - IdiPaz, Madrid, Spain, 6Department of Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, 7Leiden University Medical Center, Leiden, Netherlands, 8Rheumatology Department, Fundación Hospital Alcorcon, Alcorcon, Madrid, Spain

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: chronic low back pain, Diagnostic Tests, magnetic resonance imaging (MRI) and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment III

Session Type: Abstract Submissions (ACR)

Background/Purpose: CBP is often the starting point for a suspicion of axSpA. In the ASAS-criteria for axial SpA either MRI of the SI-joints or HLA-B27-testing are dominant. But, CBP is an extremely common presenting symptom and not all patients can be followed up by MRI and/or HLAB27 testing. This analysis was undertaken to investigate which characteristics of back-pain forecast a positive MRI of the SI-joints.

Objectives: To evaluate which inflammatory characteristics of CBP are associated with the presence of sacroiliitis on MRI in patients with a suspicion of axSpA.

Methods: Baseline dataset from the EsPeranza cohort (<45 years old, symptoms duration 3-24 months and with inflammatory back pain -IBP- or asymmetrical arthritis or spinal/joint pain plus ≥1 SpA features) was used. For this study, only data from all patients with axial symptoms who underwent sacroiliac joint (SIJ) MRI were analysed. Univariable and multivariable logistic regression analyses were employed to estimate odds ratio for the association between IBP characteristics (morning stiffness, improve with exercise and not with rest, alternating buttock pain, insidious onset, awakening at 2nd half of night and good response to NSAID) and their different combinations with a positive SIJ MRI (ASAS definition). Furthermore, diagnostic utility measures were also calculated.

Results: Data from 326 patients (53.7% male, 45% HLA-B27 positive, mean (SD) age 32.8 (7) years and mean (SD) symptoms duration 12.6 (6.4) months) were included in this analysis. A total of 130 (40%) patients had sacroiliitis on MRI. Table shows the association between each separate characteristic (1A) and each possible IBP definition (1B) with a positive MRI. Alternating buttock pain (OR=3.43;p<0.001), insidious onset (OR=2.15;p<0.05) and awakening at 2nd half of the night (OR=1.71;p<0.05) were significantly and positively associated with a positive MRI. The combination of these three characteristics (92%) and the addition to the ASAS-definition of IBP of alternating buttock pain (94%) or NSAID response (86%) had highest specificity, but insufficient sensitivity.

Conclusion: Alternating buttock pain is a distinguishing IBP characteristic strongly associated with a positive SIJ MRI in patients with suspected axSpA. The addition of this criterion in the decision to perform MRI of the SIJ may improve diagnostic efficiency in patients with suspected axSpA.

Acknowledgements: The EsPeranza Program has been supported by an unrestricted grant from Pfizer

Disclosure of Interest: None declared

Table: Association between each of the CBP characteristics and each of the possible IBP definitions with a positive MRI.

 

Sacroiliitis positive

(N=130)

Sacroiliitis negative

(N=196)

Univariable

analysis

Multivariable analysis

Diagnostic utility measures

N (%)

N (%)

OR

OR

Sen

Spe

PPV

NPV

LR+

LR-

Table 1A: Individual Characteristic of IBP

Morn. Stiff  > 30 min

89 (68.5)

106 (54.1)

1.84*

1.30

68.5

45.9

45.6

68.7

1.27

0.69

Imp. exercise,  not rest

41 (31.5)

56 (28.6)

1.15

31.5

71.4

42.3

61.1

1.10

0.04

Alter. buttock pain

62 (47.7)

36 (18.4)

4.05**

3.43**

47.7

81.6

63.3

70.2

2.59

0.64

Insidious onset

114 (87.7)

142 (72.4)

2.71**

2.15*

87.7

27.6

44.5

77.1

1.21

0.44

Awake 2nd half night

84 (64.6)

85 (43.4)

2.39**

1.71*

64.6

56.6

49.7

70.7

1.49

0.63

Response to NSAIDs

90 (69.2)

110 (56.1)

1.76*

1.32

69.2

43.9

45.0

68.3

1.23

0.70

Table 1B: IBP Definition

Calin criteria

67 (51.5)

57 (29.1)

2.59**

–

51.5

70.9

54.0

68.8

1.77

0.68

Berlin criteria

94 (72.3)

97 (49.5)

2.67**

–

72.3

50.5

49.2

73.3

1.46

0.55

ASAS criteria

62 (47.7)

45 (23.0)

3.06**

–

47.7

77.0

57.9

68.9

1.45

0.67

Night + Insidious + Buttock (2/3)

93 (71.5)

80 (40.8)

3.65**

71.5

59.2

53.8

75.8

1.75

0.48

Night + Insidious + Buttock (3/3)

89 (33.8)

15 (7.7)

6.17**

–

33.8

92.3

74.6

67.8

4.39

0.72

Calin + Night (5/6)

52 (40.0)

41 (20.9)

2.52**

–

40.0

79.1

55.9

66.5

1.91

0.76

Berlin + Insidious (3/5)

89 (68.5)

81 (41.3)

3.08**

–

68.5

58.7

52.4

73.7

1.66

0.54

ASAS + Buttock (5/6)

40 (30.8)

11 (5.6)

7.48**

–

30.8

94.4

78.4

67.3

5.50

0.73

ASAS + NSAIDs (5/6)

48 (36.9)

27 (13.8)

3.66**

–

36.9

86.2

64.0

67.3

2.67

0.73

ASAS + Buttock + NSAIDs (6/7)

28 (21.5)

7 (3.6)

7.41**

–

21.5

96.4

80.0

64.9

5.97

0.81

p<0.05;**p<0.001


Disclosure:

V. Navarro-Compán,
None;

R. Almodóvar González,
None;

A. Hernández,
None;

E. Beltrán,
None;

E. De Miguel,
None;

R. B. M. Landewé,
None;

D. van der Heijde,
None;

P. Zarco,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/which-characteristics-of-inflammatory-back-pain-cbp-forecast-the-presence-of-sacroiliitis-on-magnetic-resonance-imaging-mri-results-from-the-esperanza-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology